{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:47:49Z","timestamp":1790279269173,"version":"4.1.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontierspartnerships.org"],"crossmark-restriction":true},"short-container-title":["Br J Biomed Sci"],"abstract":"<jats:p>\n                    <jats:bold>Introduction:<\/jats:bold>\n                    Diabetes is a leading risk factor for cardiovascular disease (CVD), the pathophysiology of both being linked to metabolic, endothelial, renal, angiogenic and platelet abnormalities. We hypothesised that abnormalities in these systems are more adverse in those whose CVD is compounded by diabetes, compared to those with diabetes or CVD alone.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Materials and methods:<\/jats:bold>\n                    Serum or plasma from 66 patients with diabetes alone, 76 with CVD alone, and 70 with both diabetes and CVD i.e. diabetic cardiovascular disease, was probed for markers of angiogenesis [angiopoietin 1 and 2, vascular endothelial growth factor (VEGF) and endoglin], metabolic [soluble receptor for advanced glycation products (sRAGE), leptin, lipocalin-2, interleukin-8, and cystatin-C], the endothelium (von Willebrand factor, endothelial microparticles and soluble E selectin)], and the platelet (platelet microparticles and soluble P selectin) by ELISA, Luminex or flow cytometry.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    VEGF (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.04), von Willebrand factor (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.001) and endothelial microparticles (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.042) were all higher in diabetic cardiovascular disease than in diabetes alone and cardiovascular disease alone. Soluble E selectin was higher in diabetic cardiovascular disease than in diabetes alone (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.045), whilst cystatin-C (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.004) and soluble P selectin (\n                    <jats:italic>p<\/jats:italic>\n                    &amp;lt; 0.001) were higher in diabetes and diabetic cardiovascular disease than in cardiovascular disease alone. There were no differences in angiopoietin 1 or 2, endoglin, sRAGE, leptin, lipocalin-2, or interleukin-8.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    Angiopoietin 1 or 2, endoglin, sRAGE, leptin, lipocalin-2, interleukin-8, and cystatin-c cannot differentiate diabetes from cardiovascular disease, or both conditions combined. Our data point to a more adverse endothelial (von Willebrand factor, endothelial microparticles), and angiogenic profile (VEGF) in those with diabetic cardiovascular disease, supporting the view that this group should be targeted more aggressively.\n                  <\/jats:p>","DOI":"10.3389\/bjbs.2022.10313","type":"journal-article","created":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T08:20:36Z","timestamp":1647937236000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Angiogenesis, Metabolism, Endothelial and Platelet Markers in Diabetes and Cardiovascular Disease"],"prefix":"10.3389","volume":"79","author":[{"given":"A. D.","family":"Blann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. E.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Heitmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.3390\/ijms21051835","article-title":"The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation","volume":"21","author":"Poznyak","year":"2020","journal-title":"Ijms"},{"key":"B2","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1042\/ebc20170054","article-title":"The Biochemical Basis of Disease","volume":"62","author":"Barr","year":"2018","journal-title":"Essays Biochem"},{"key":"B3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fcell.2018.00082","article-title":"Endothelial Cell Metabolism in Atherosclerosis","volume":"6","author":"Theodorou","year":"2018","journal-title":"Front Cell Dev. Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1161\/circresaha.116.302855","article-title":"Endothelial Cell Metabolism in normal and Diseased Vasculature","volume":"116","author":"Eelen","year":"2015","journal-title":"Circ Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/10408363.2020.1791045","article-title":"The Role of Soluble Receptor for Advanced Glycation End-Products (sRAGE) in the General Population and Patients with Diabetes Mellitus with a Focus on Renal Function and Overall Outcome","volume":"58","author":"Steenbeke","year":"2021","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5551\/jat.rv17016","article-title":"Cysteine Protease Cathepsins in Atherosclerotic Cardiovascular Diseases","volume":"25","author":"Wu","year":"2018","journal-title":"Jat"},{"key":"B7","doi-asserted-by":"publisher","first-page":"248","DOI":"10.7570\/jomes20120","article-title":"Leptin as a Key between Obesity and Cardiovascular Disease","volume":"29","author":"Kang","year":"2020","journal-title":"J Obes Metab Syndr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1159\/000368474","article-title":"Diagnostic and Prognostic Utility of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Patients with Cardiovascular Diseases - Review","volume":"39","author":"Helanova","year":"2014","journal-title":"Kidney Blood Press Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"332","DOI":"10.5551\/jat.3939","article-title":"Adipose Tissue, Inflammation and Atherosclerosis","volume":"17","author":"Gustafson","year":"2010","journal-title":"Jat"},{"key":"B10","doi-asserted-by":"publisher","first-page":"w20011","DOI":"10.4414\/smw.2019.20011","article-title":"Vascular Endothelial Growth Factor Biology for Regenerative Angiogenesis","volume":"149","author":"Uccelli","year":"2019","journal-title":"Swiss Med Wkly"},{"key":"B11","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/moh.0000000000000361","article-title":"Angiopoietins and Tie2 in Vascular Inflammation","volume":"24","author":"Parikh","year":"2017","journal-title":"Curr Opin Hematol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2147\/vhrm.s29144","article-title":"Endoglin: a Critical Mediator of Cardiovascular Health","volume":"9","author":"Kapur","year":"2013","journal-title":"Vhrm"},{"key":"B13","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/moh.0000000000000230","article-title":"Regulation of VWF Expression, and Secretion in Health and Disease","volume":"23","author":"Xiang","year":"2016","journal-title":"Curr Opin Hematol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e003048","DOI":"10.1161\/JAHA.115.003048","article-title":"Novel Biomarkers to Improve the Prediction of Cardiovascular Event Risk in Type 2 Diabetes Mellitus","volume":"5","author":"van der Leeuw","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"B15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2147\/COPD.S38931","article-title":"The Role of Microparticles in Chronic Obstructive Pulmonary Disease","volume":"9","author":"Takahashi","year":"2014","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/07853890.2019.1609076","article-title":"Microparticles and Cardiovascular Diseases","volume":"51","author":"Voukalis","year":"2019","journal-title":"Ann Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.4103\/2319-4170.113231","article-title":"Plasma P-Selectin Predicts Long-Term Cardiovascular Events in Hospitalized Patients with Suspected Coronary Artery Disease and Preserved Left Ventricular Function: a 10-year Follow-Up Study","volume":"36","author":"Chen","year":"2013","journal-title":"Biomed J"},{"key":"B18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11239-016-1427-3","article-title":"Relationship between Renal Function and Circulating Microparticles, Soluble P-Selectin and E-Selectin Levels in Atrial Fibrillation","volume":"43","author":"Lau","year":"2017","journal-title":"J Thromb Thrombolysis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1161\/circheartfailure.111.962365","article-title":"Ethnic Differences in Macrovascular and Microvascular Function in Systolic Heart Failure","volume":"4","author":"Shantsila","year":"2011","journal-title":"Circ Heart Fail"},{"key":"B20","article-title":"National Institute for Health and Care Excellence","year":"2021"},{"key":"B21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11886-019-1246-1","article-title":"Management of Lipid Abnormalities in Patients with Diabetes","volume":"21","author":"Sillars","year":"2019","journal-title":"Curr Cardiol Rep"},{"key":"B22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s12325-018-0824-8","article-title":"Body Weight Considerations in the Management of Type 2 Diabetes","volume":"36","author":"Apovian","year":"2019","journal-title":"Adv Ther"},{"key":"B23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13098-019-0476-0","article-title":"Consensus Recommendations for Management of Patients with Type 2 Diabetes Mellitus and Cardiovascular Diseases","volume":"11","author":"Bashier","year":"2019","journal-title":"Diabetol Metab Syndr"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.cjca.2018.07.010","article-title":"CardioDiabetes: Core Competencies for Cardiovascular Clinicians in a Rapidly Evolving Era of Type 2 Diabetes Management","volume":"34","author":"Mancini","year":"2018","journal-title":"Can J Cardiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1007\/s00125-009-1470-0","article-title":"Intensive Glucose Control and Macrovascular Outcomes in Type 2 Diabetes","volume":"52","author":"Turnbull","year":"2009","journal-title":"Diabetologia"},{"key":"B26","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2217\/bmm-2020-0611","article-title":"Cardiovascular Risk Assessment and Association with Novel Biomarkers in Patients with Type 2 Diabetes Mellitus","volume":"15","author":"N\u00e9ri","year":"2021","journal-title":"Biomarkers Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.3390\/cells9061452","article-title":"Oxidative Stress Induces a VEGF Autocrine Loop in the Retina: Relevance for Diabetic Retinopathy","volume":"9","author":"Rossino","year":"2020","journal-title":"Cells"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e20562","DOI":"10.1097\/md.0000000000020562","article-title":"Retinal Blood Oxygen Saturation and Vascular Endothelial Growth Factor-A in Early Diabetic Retinopathy","volume":"99","author":"Qiu","year":"2020","journal-title":"Medicine"},{"key":"B29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40942-019-0179-6","article-title":"Serum Vascular Endothelial Growth Factor Is a Biomolecular Biomarker of Severity of Diabetic Retinopathy","volume":"5","author":"Ahuja","year":"2019","journal-title":"Int J Retin Vitr"},{"key":"B30","first-page":"1453","article-title":"Expression of Vascular Endothelial Growth Factor in the Human Retina and in Nonproliferative Diabetic Retinopathy","volume":"152","author":"Gerhardinger","year":"1998","journal-title":"Am J Pathol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3980\/j.issn.2222-3959.2014.04.11","article-title":"Effects of Laser Photocoagulation on Serum Angiopoietin-1, Angiopoietin-2, Angiopoietin-1\/angiopoietin-2 Ratio, and Soluble Angiopoietin Receptor Tie-2 Levels in Type 2 Diabetic Patients with Proliferative Diabetic Retinopathy","volume":"7","author":"You","year":"2014","journal-title":"Int J Ophthalmol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1136\/bjo.2004.048587","article-title":"Plasma Vascular Endothelial Growth Factor, Angiopoietin-2, and Soluble Angiopoietin Receptor Tie-2 in Diabetic Retinopathy: Effects of Laser Photocoagulation and Angiotensin Receptor Blockade","volume":"88","author":"Lip","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1471-2261-11-31","article-title":"Circulating Angiopoietins-1 and -2, Angiopoietin Receptor Tie-2 and Vascular Endothelial Growth Factor-A as Biomarkers of Acute Myocardial Infarction: a Prospective Nested Case-Control Study","volume":"11","author":"Iribarren","year":"2011","journal-title":"BMC Cardiovasc Disord"},{"key":"B34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1475-2840-12-34","article-title":"Changes of Serum Angiogenic Factors Concentrations in Patients with Diabetes and Unstable Angina Pectoris","volume":"12","author":"Gui","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1582-4934.2005.tb00499.x","article-title":"Elevated Plasma CD105 and Vitreous VEGF Levels in Diabetic Retinopathy","volume":"9","author":"Malik","year":"2005","journal-title":"J Cell. Mol Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1741-7015-8-86","article-title":"Increased Plasma Soluble Endoglin Levels as an Indicator of Cardiovascular Alterations in Hypertensive and Diabetic Patients","volume":"8","author":"Bl\u00e1zquez-Medela","year":"2010","journal-title":"BMC Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1007\/s00018-020-03701-w","article-title":"Membrane and Soluble Endoglin Role in Cardiovascular and Metabolic Disorders Related to Metabolic Syndrome","volume":"78","author":"Vicen","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1177\/0003319720903586","article-title":"Novel Biomarkers for Evaluation of Endothelial Dysfunction","volume":"71","author":"Leite","year":"2020","journal-title":"Angiology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e1003513","DOI":"10.1371\/journal.pmed.1003513","article-title":"Plasma Proteins Associated with Cardiovascular Death in Patients with Chronic Coronary Heart Disease: A Retrospective Study","volume":"18","author":"Wallentin","year":"2021","journal-title":"Plos Med"},{"key":"B40","doi-asserted-by":"crossref","first-page":"890","DOI":"10.2741\/4758","article-title":"Mechanisms of Obesity-Induced Metabolic and Vascular Dysfunctions","volume":"24","author":"Atawia","year":"2019","journal-title":"Front Biosci (Landmark Ed"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/j.jacc.2004.07.050","article-title":"Plasma Leptin and Prognosis in Patients with Established Coronary Atherosclerosis","volume":"44","author":"Wolk","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1177\/1741826711398179","article-title":"Methods for Evaluating Endothelial Function: a Position Statement from the European Society of Cardiology Working Group on Peripheral Circulation","volume":"18","author":"Lekakis","year":"2011","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"B43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1160\/th05-07-0527","article-title":"Plasma von Willebrand factor, thrombosis, and the endothelium: the first 30 years","volume":"95","author":"Blann","year":"2006","journal-title":"Thromb Haemost"},{"key":"B44","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.cca.2008.09.018","article-title":"Soluble P-Selectin as a Marker of In Vivo Platelet Activation","volume":"399","author":"Ferroni","year":"2009","journal-title":"Clinica Chim Acta"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1161\/01.cir.0000129773.70647.94","article-title":"Soluble CD40 Ligand, Soluble P-Selectin, Interleukin-6, and Tissue Factor in Diabetes Mellitus","volume":"109","author":"Lim","year":"2004","journal-title":"Circulation"}],"container-title":["British Journal of Biomedical Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/bjbs.2022.10313\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T08:20:42Z","timestamp":1647937242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/bjbs.2022.10313\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,22]]},"references-count":45,"alternative-id":["10.3389\/bjbs.2022.10313"],"URL":"https:\/\/doi.org\/10.3389\/bjbs.2022.10313","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1087225\/v1","asserted-by":"object"}]},"ISSN":["2474-0896"],"issn-type":[{"value":"2474-0896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,22]]},"article-number":"10313"}}